Form 4: Zoetis Executive Vice President Acquires Phantom Stock Units

Executive Vice President of Zoetis Inc., Robert J Polzer, reports acquisition of phantom stock units through the Zoetis Supplemental Savings Plan.

Summary

• On October 4, 2024, Robert J Polzer, Executive Vice President of Zoetis Inc., acquired 145.4836 phantom stock units through the Zoetis Supplemental Savings Plan.
• The price of the phantom stock units was $61.07.
• Following the transaction, Polzer beneficially owns 9,099.7188 phantom stock units.
• These phantom stock units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
• Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit).

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The acquisition of phantom stock units by an executive is generally viewed as a mildly positive sign, suggesting confidence in the company's future.

Positives

• The acquisition of phantom stock units by an executive may reflect confidence in the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the acquisition of phantom stock units could be interpreted as a positive signal regarding the executive's outlook on the company's future.

Industry Context

Executive compensation through stock and phantom stock units is a common practice in publicly traded companies to align management's interests with those of shareholders. This Form 4 filing provides transparency into the equity-based compensation of a key executive at Zoetis.

Comparison to Industry Standards

• Zoetis, as a major player in the animal health industry, often benchmarks its executive compensation practices against peers like Elanco, Merck Animal Health, and Boehringer Ingelheim Animal Health.
• Phantom stock units are a fairly standard component of executive compensation packages in similar large cap companies, offering a cash-settled benefit tied to the company's stock performance without diluting existing shareholders.
• The specific terms and conditions of Zoetis' Supplemental Savings Plan, including vesting schedules and transfer restrictions, would need to be compared to those of similar plans at competitor companies to fully assess its competitiveness.

Stakeholder Impact

• The acquisition of phantom stock units by an executive can have a minor positive impact on shareholder sentiment, as it aligns management's interests with those of the shareholders.
• The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates